All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, February 8, 2023
Home » Topics » Analysis and data insight

Analysis and data insight
Analysis and data insight RSS Feed RSS

FDA approved icons and medical professional

NMEs and CRLs both hit seven in 2022’s first two months

March 4, 2022
By Karen Carey
No Comments
A total of seven new molecular entities (NME) have been approved by the U.S. FDA this year, while another seven therapies received dreaded complete response letters from the agency. Out of 9 FDA approvals in February, including two BLAs, three NDAs, three supplemental applications, and one abbreviated NDA, were three NME clearances.
Read More

Biggest gainers and losers for the week of Feb. 28-March 4, 2022

March 4, 2022
No Comments
The top 10 biopharma stock gainers and losers for the week.
Read More

Biopharma money raised: Jan. 1-March 3, 2022

March 4, 2022
No Comments
Year-to-date money raised in public, private and other financings of biopharma companies.
Read More

BioWorld and Nasdaq stock indices

March 4, 2022
No Comments
These graphs compare the performance of the biotech stocks for all of 2021 using the BioWorld Stock Indicator and the Nasdaq Biotech Index.
Read More

Money raised by biopharma: 2022 vs. 2021 vs. 2020 vs. 2019

March 4, 2022
No Comments
Total raised in public, private and other financings of biopharma companies, comparing 2022 vs. 2021 vs. 2020 vs. 2019.
Read More

Med-tech gainers and losers for Feb. 28 to March 4, 2022

March 4, 2022
No Comments
The top 10 med-tech stock gainers and losers for the week.
Read More
Clinical data illustration

With fewer pandemic updates, clinical data down by 11%

March 3, 2022
By Karen Carey
No Comments
While clinical trial updates in 2022 started off slow, the gap with last year appears to be closing, even as pandemic activity diminishes.
Read More
Coronavirus, question marks

Origin and efficacy questions mount; new MAb, protein vaccines, take the stage

March 1, 2022
By Karen Carey
No Comments
Two years ago, BioWorld reported on 30 therapeutics and vaccines in development for COVID-19, about 3,000 people had died from the disease, and societal lockdowns began. Today, therapeutics and vaccines have ballooned to 1,048, deaths are at 6 million, and the world remains on edge due to highly transmissible variants and breakthrough infections. One thing remains the same: Scientists still do not know where the SARS-CoV-2 virus originated.
Read More

Biggest gainers and losers for the week of Feb. 22-25, 2022

Feb. 25, 2022
No Comments
The top 10 biopharma stock gainers and losers for the week.
Read More

Biopharma money raised: Jan. 1-Feb. 24, 2022

Feb. 25, 2022
No Comments
Year-to-date money raised in public, private and other financings of biopharma companies.
Read More
Previous 1 2 … 31 32 33 34 35 36 37 38 39 … 154 155 Next

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld
    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus pandemic. They are available for free with registration. Note...
  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 8, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Feb. 8, 2022.
  • Setpoint Medical - vagus nerve stimulation device

    Setpoint Medical lands up to $145M to advance RA implant

    BioWorld MedTech
    Bioelectronic medicine startup Setpoint Medical Corp. raised $80 million in a preferred stock financing co-led by new investors Norwest Venture Partners and...
  • Brain with clock hands, day and night background

    12-Hour as well as circadian brain rhythms disrupted in people with schizophrenia

    BioWorld Science
    Research shows that individuals with schizophrenia have abnormal gene expression patterns in their brains compared with people without the condition. In a study...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing